Managing risks
A closer look at the legislative proposals on pharmacovigilance
Wednesday 27 January 2010 12:30-15:00 | |
| 12:0012:30 | Registration |
13:0013:10 | Introduction |
13:1013:20 | Medicines' Adverse Reactions are a public health issue: a proactive approach is needed |
13:20 13:30 | How to deal with adverse drug reactions reports? The role of National and regional pharmacovigilance centres |
| 13:30-13:45 | The European Commission's Pharmacovigilance proposals: more than a technical issue |
| 13:45-13:55 | Direct patient reporting: what works and why it matters. Findings of an international survey |
| 13:55-14:05 | Access to pharmacovigilance information Patients and consumers' demands Interventions from: |
| 14:05-14:15 | Comments by the co-chairs, MEP Philippe Juvin and MEP Antonyia Parvanova |
| 14:15-14:45 | Open discussion moderated by MEP Michèle Rivasi |
| 14:45-15:00 | Conclusion by the MEPs |
Light lunch and refreshments will be available before the start of the meeting at 12:30h An overflow room will be available with live broadcast of the meeting This event is facilitated by:
The Greens/EFA in the European Parliament,Association Internationale de la Mutualité (AIM), European Consumers' Organisation (BEUC), Health Action International (HAI) Europe, the International Society of Drug Bulletins (ISDB) and Medicines in Europe Forum (MiEF).
